Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kiran Patel

Anesthesiology New York, NY Medical Doctor

NPI 1629202981 CMS profile 28672

5 Columbus Circle 10Th Fl, New York, NY 10019

Open in the dashboard

General payments

$831,990

1,310 records reported · program years 2019–2025

Research payments

$958

Paid to them · 4 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kiran Patel of New York, NY is reported in the CMS Open Payments database as having received $831,990 across 1,310 general payments and $958 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $185,585 248
2024 General $144,446 215
2023 General $172,808 184
2022 General $298,191 465
2021 General $29,612 179
2021 Research $130 2
2020 General $1,186 14
2020 Research $828 2
2019 General $163 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kiran Patel
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Kiran Patel were reported at $185,585. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Kiran Patel Anesthesiology median Middle half National median
2019 $163 $72 $23–$151 $163
2020 $1,186 $36 $17–$120 $114
2021 $29,612 $49 $21–$135 $132
2022 $298,191 $52 $22–$144 $149
2023 $172,808 $53 $23–$143 $160
2024 $144,446 $55 $25–$150 $164
2025 $185,585 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $533,313 851 payments
  2. MML US, Inc. $86,538 88 payments
  3. Boston Scientific Corporation $56,007 79 payments
  4. GRT US Holding, Inc. $30,479 42 payments
  5. Relievant Medsystems, Inc. $26,105 64 payments
  6. Vertos Medical, Inc. $23,979 21 payments
  7. Saluda Medical Americas, Inc. $22,418 24 payments
  8. BIOTRONIK NRO, Inc. $18,733 35 payments
  9. SPR Therapeutics, Inc $13,406 33 payments
  10. Vertex Pharmaceuticals Incorporated $12,299 12 payments
  11. Other $8,714 61 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $281,039 163 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $230,065 185 payments
  3. Consulting Fee $179,878 108 payments
  4. Travel and Lodging $77,773 249 payments
  5. Food and Beverage $40,581 595 payments
  6. Honoraria $22,400 8 payments
  7. Grant $242 1 payment
  8. Education $12 1 payment
Products named General payments · program years 2019–2025
  1. PROCLAIM Neuromodulation $324,987 390 payments
  2. PROCLAIM Neuromodulation $101,971 159 payments
  3. ReActiv8 $86,538 88 payments
  4. PROCLAIM Structural Heart $70,845 78 payments
  5. Qutenza $30,479 42 payments
  6. Intracept Pain $26,575 49 payments
  7. Intracept Contains (1)Intracept RF Probe (2)Intracept Access Instruments_NMOD $24,940 20 payments
  8. mild Device Kit $23,979 21 payments
  9. Intracept Pain $19,746 37 payments
  10. Evoke $14,292 5 payments
  11. Other $121,964 482 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Abbott Laboratories $828 2 payments
  2. Saluda Medical Americas, Inc. $130 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

109

Median for Pain Management: 951

Drug cost

$1,885

Median for Pain Management: $26,034

Branded share of claims

21.1%

Median for Pain Management: 29.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Pregabalin Generic 35 $1,050
Gabapentin Generic 28 $471
Oxycodone Hcl Generic 23 $201
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 23 $163

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,732 Part D prescribers listed as Pain Management; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 49 billing codes

Paid by Medicare

$241,612

Of which drugs: $314

Medicare patients

287

Average age 75

Services billed

5,053

177 women, 110 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 66%
Ischemic heart disease 38%
Osteoporosis 30%
Diabetes 29%
Depression 26%
Cancer 17%
COPD 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 139 3,530 $314

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,314 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record